Pharmaco - Press Releases

Date	Title	Company
20-Sep-2021	Leading Microbiologists to meet at SMi’s 10th Annual Pharmaceutical Microbiology Conference	SMi Group
20-Sep-2021	DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS	Defence Therapeutics Inc.
20-Sep-2021	Vita 34 AG launches voluntary public exchange offer for PBKM shares	Vita 34 AG
17-Sep-2021	Biotest AG: Takeover Offer: Grifols S.A. to make a voluntary public takeover offer for the shares of Biotest AG	Biotest AG
16-Sep-2021	Loos, France, Isovital Headquarter, Sept 15th 2021 - Radiopharma Logistics Group (RLG); ISOTOPES SERVICES INTERNATIONAL (ISI) : ISI is back !	Radio Pharma Logistics Group (RLG)
16-Sep-2021	Pharma Logistics Masterclass for Pharma Industry and Academics held in Antwerp, Belgium Concluded with Great Success	Pharma Aero
16-Sep-2021	Novo Nordisk Foundation and Broad Institute of MIT and Harvard launch new research center for genomic mechanisms of disease	Novo Nordisk
16-Sep-2021	4D pharma presents two clinical posters for Live Biotherapeutic MRx0518 at the European Society for Medical Oncology (ESMO) Congress 2021	4D pharma
16-Sep-2021	PAION AG ANNOUNCES INITIATION OF PIVOTAL STUDY OF REMIMAZOLAM (BYFAVO(R)) IN PEDIATRIC PROCEDURAL SEDATION	PAION AG
16-Sep-2021	aap Implantate AG significantly raises EBITDA forecast for financial year 2021	aap Implantate AG
16-Sep-2021	Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand	Vifor Pharma
16-Sep-2021	Medigene AG: Medigene's PD1-41BB switch receptor improves TCR-T cell functionality against solid tumors	Medigene AG
16-Sep-2021	Enterome highlights Microbiome publication describing sibofimloc’s novel mechanism of action for the treatment of Crohn’s disease	Enterome
16-Sep-2021	Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation Non-viral Gene Therapies	Anjarium Biosciences
16-Sep-2021	European Parliament votes in favour of EU plan to replace animal experiments with cutting-edge science	European Parliament
16-Sep-2021	DFE Pharma Launches BioHale® Trehalose to offer Pharma customers increased stability in Biologics	DFE Pharma
16-Sep-2021	NICE Recommends BioCryst’s ORLADEYO®▼(berotralstat), an Oral, Once-Daily Therapy, to Prevent Recurrent Attacks of Hereditary Angioedema in Patients 12 Years and Older	BioCryst Pharmaceuticals
16-Sep-2021	SynBiotic SE: Christian Angermayer now largest shareholder with circa 45%	SynBiotic SE
16-Sep-2021	PharmaSGP: Product portfolio further expanded and internationalisation driven forward in H1 2021	PharmaSGP Holding SE
16-Sep-2021	Newron announces Half-Year 2021 results	Newron Pharmaceuticals SpA